Ambee Pharmaceuticals PLC announcements
253 Dhaka Stock Exchange announcements for Ambee Pharmaceuticals PLC (AMBEEPHA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (26).
- Resumption after record date
Trading of the shares of the Company will resume on 13.12.2022 after record date.
- Regarding record date for entitlement of Stock Dividend
Refer to their earlier news disseminated by DSE on 22.11.2022 regarding dividend declaration and increase of Authorized Capital, the company has further informed that they made an application to BSEC for issuance of 20% Stock dividend but they have not received approval yet. So they will notify another record date later for entitlement of Stock Dividend if they get approval from BSEC. However, the record date as on 12.12.2022 will be applicable for entitlement of 10% Cash dividend.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 12.12.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 08.12.2022 to 11.12.2022. Trading of the shares will remain suspended on record date i.e., 12.12.2022.
- The auditor of the Ambee Pharmaceuticals Ltd. has given the \"Qualified Opinion\" paragraph in the Auditor\'s Report for
The auditor of the Ambee Pharmaceuticals Ltd. has given the \"Qualified Opinion\" paragraph in the Auditor\'s Report for the year ended June 30, 2022. Basis for Qualified Opinion: 1. As disclosed in note # 19.00, the company has shown Tk. 10,459,676 as liabilities for WPF & WWF which includes prior year\'s amount of Tk. 9,948,826. Out of the prior year\'s amount an amount of Tk. 1,144,988 has been paid by the company. (cont.1)
- (Continuation news of AMBEEPHA): As per section 234 (b) of Labour Act, 2006 the company should pay the amount to the WPF
(Continuation news of AMBEEPHA): As per section 234 (b) of Labour Act, 2006 the company should pay the amount to the WPF & WWF not later than nine months from the end of the respective year. Incase of failure penalty as per section 236 may be imposed. However, for utilization of the fund the company provided interest as per section 240. 2. As disclosed in note # 17.02, the company has shown Tk. 1,916,358 as Payable to Provident Fund. (cont.2)
The first part of this announcement is missing from the archive. - (Continuation news of AMBEEPHA): The amount is carried forward from earlier years. As no Financial Statement of Providen
(Continuation news of AMBEEPHA): The amount is carried forward from earlier years. As no Financial Statement of Provident Fund was made available to us, so we are not sure whether there is any forfeited fund returned to company\'s account from the contributory provident fund as per notification no. 179/FRC/FRM/2020/2, dated July 07, 2020 of the Financial Reporting Council (FRC). 3. As disclosed in note # 20.00, the company has shown an amount of (cont.3)
The first part of this announcement is missing from the archive. - (Continuation news of AMBEEPHA): Tk. 2,356,352 as Unclaimed Dividend as at 30.06.2022. The amount has arrived at after p
(Continuation news of AMBEEPHA): Tk. 2,356,352 as Unclaimed Dividend as at 30.06.2022. The amount has arrived at after payment of Tk. 1,500,000 to the Capital Market Stabilization Fund (CMSF) as per directive of Bangladesh Securities and Exchange Commission (BSEC) No. SEC/SRMlC/165-2020/part-1/202 dated 25 August 2021. The designated bank account for dividend has shown a balance of Tk. 153,954 as at 30.06.2022. (cont.4)
The first part of this announcement is missing from the archive. - Qualified Opinion
(Continuation news of AMBEEPHA): Hence, there is a shortfall in the dividend bank account. This is a non-compliance of the section 28 (1) of Dhaka Stock Exchange (Listing) Regulations, 2015. (end)
The first part of this announcement is missing from the archive. - Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.25 for July-September 2022 as against Tk. 0.10 for July-September 2021; NOCFPS was Tk. 4.34 for July-September 2022 as against Tk. 8.37 for July-September 2021. NAV per share was Tk. 22.20 as on September 30, 2022 and Tk. 21.96 as on June 30, 2022.
- The company has further informed that the stock dividend declared by them is subject to the approval of Bangladesh Secur
The company has further informed that the stock dividend declared by them is subject to the approval of Bangladesh Securities and Exchange Commission as per BSEC Notification No. BSEC/CMRRCD/2009-193/46/Admin/138 dated October 03, 2022. Record date: 12.12.2022. The company has also informed that i) The reason for the declaration of Stock Dividend is to raise minimum paid-up capital of Tk. 30.00 crore as per (cont.)
- Update of Information
The Company has requested the Shareholders who changed/amended their e-mail addresses or opened new e-mail addresses after the Record Date to e-mail the details to [email protected] along with full name, Folio/BO ID to receive the digital platform meeting invitation. The Company has also requested the Shareholders to notify 12-digit Taxpayer's Identification Number (E-TIN) through their respective Depository Participants.
- Dividend Declaration (Additional Information)
(Continuation news of AMBEEPHA): regulatory requirement. ii) They have declared the Stock Dividend from the profit of Financial Year 2021- 2022. iii) They have not declared such stock dividend or bonus shares from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the company or through reducing paid up capital or through doing anything so that the post-dividend retained earnings become negative or a debit balance. (end)
The first part of this announcement is missing from the archive. - The Board of Directors has recommended 10\% Cash and 20\% Stock dividend for the year ended June 30, 2022. DSE has sent
The Board of Directors has recommended 10\% Cash and 20\% Stock dividend for the year ended June 30, 2022. DSE has sent a query letter to the company as they have not complied Conditions 2 and 3(a) of BSEC Notification No.- BSEC/CMRRCD/2009-193/46/Admin/138 dated October 03, 2022 regarding declaration of stock dividend. Date of AGM: 31.12.2022, Time: 11:00 AM, Venue: Digital Platform. Record date: will be notified later on. (cont.1)
- (Continuation news of AMBEEPHA): The Company has also reported EPS of Tk. 3.36, NAV per share of Tk. 21.96 and NOCFPS of
(Continuation news of AMBEEPHA): The Company has also reported EPS of Tk. 3.36, NAV per share of Tk. 21.96 and NOCFPS of Tk. (30.49) for the year ended June 30, 2022 as against Tk. (5.42), Tk. 18.68 and Tk. (2.27) respectively for the same period of the previous year. The company has further informed that the following agenda as special business, among others, will be placed for approval in the AGM: i) To change the name of the Company from Ambee Pharmaceuticals Limited to (cont.2)
The first part of this announcement is missing from the archive. - Dividend Declaration (Correction News)
(Correction News): The correction news will be Conditions 2 and 3(c) of BSEC Notification instead of Conditions 2 and 3(a) of BSEC Notification. Other information will remain unchanged.
- Dividend Declaration and Increase of Authorized Capital
(Continuation news of AMBEEPHA): Ambee Pharmaceuticals PLC as to amend Clause 1 of Memorandum of Association of the Company. ii) To increase the Authorized Capital of the Company from Tk. 2.50 crore to Tk. 30.00 crore and to amend the Clause 5 and Article 4 and Article 53 of the Memorandum and Articles of Association of the Company. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 27, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (22.11.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 21, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Appointment of Managing Director
The Company has informed that Ms. Kazi Tanzzina Ferdous, has been appointed as the Managing Director of the Company.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.40 for January-March 2022 as against Tk. 0.30 for January-March 2021; EPS was Tk. 0.74 for July 2021-March 2022 as against Tk. 0.65 for July 2020-March 2021. NOCFPS was Tk. 2.18 for July 2021-March 2022 as against Tk. 3.89 for July 2020-March 2021. NAV per share was Tk. 19.42 as on March 31, 2022 and Tk. 18.68 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Bangladesh Rating Agency Limited (BDRAL) has assigned the Company as \"A-\" for long term and \"ST-3\" for short term wi
Bangladesh Rating Agency Limited (BDRAL) has assigned the Company as \"A-\" for long term and \"ST-3\" for short term with developing outlook in consideration of audited financials of the Company up to June 30, 2021, unaudited financials up to December 31, 2021 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.24 for October-December, 2021 as against Tk. 0.20 for October-December, 2020; EPS was Tk. 0.34 for July-December, 2021 as against Tk. 0.35 for July-December, 2020. NOCFPS was Tk. 4.21 for July-December, 2021 as against Tk. 0.54 for July-December, 2020. NAV per share was Tk. 18.92 as on December 31, 2021 and Tk. 18.68 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.